Party drug tested to fight MS exhaustion
NCT ID NCT05378100
Summary
This study is testing whether low doses of ketamine, given through an IV, can reduce the severe fatigue that many people with multiple sclerosis experience. Researchers at Johns Hopkins are comparing ketamine to a placebo in 110 participants to see if it improves energy levels and daily function. The trial uses careful measurements to track changes in fatigue, sleepiness, and mood over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS FATIGUE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins University
Baltimore, Maryland, 21287, United States
Conditions
Explore the condition pages connected to this study.